(Q35031888)

English

Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

object named as

Susan A Dixon

3

0 references

1

object named as

Shyam Sundar

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Prabhat K Sinha

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Renata Buckley

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ann K Miller

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Khadeeja Mohamed

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Mahir Al-Banna

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

American Journal of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

892-900

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Can visceral leishmaniasis be eliminated from Asia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Injectable paromomycin for Visceral leishmaniasis in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Drug resistance in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Comparison of the efficacy and pharmacology of formulations of amphotericin B used in treatment of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Miltefosine: an oral drug for visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Miltefosine: great expectations against visceral leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Sitamaquine (GlaxoSmithKline/Walter Reed Army Institute).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Amphotericin B nephrotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

8 July 2018

Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

25 October 2018

A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

25 October 2018

A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

25 October 2018

Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

25 October 2018

A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

25 October 2018

Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110365

25 October 2018

Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable

1 reference

https://pubmed.ncbi.nlm.nih.gov/21633025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals

1 reference

https://pubmed.ncbi.nlm.nih.gov/21633025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21633025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral treatment of visceral leishmaniasis with miltefosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21633025

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4269/AJTMH.2011.10-0409

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

release_kaxog7242rgftbb35zxyl4kcm4

1 reference

https://api.fatcat.wiki/v0/release/kaxog7242rgftbb35zxyl4kcm4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35031888&oldid=2143589117"